PHSE
Pharmhouse Corp
0.0127$
+32.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q4 24 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -499.2% | – | – | – | – | – | – | – | -2,570.9% | 1,264.6% | -30.2% | 21.6% | -37.6% | |
| – | – | – | – | – | – | – | – | – | – | 2.9% | 3.3% | – | |
| 777.3% | – | – | – | – | – | – | – | 46.2% | -45.5% | -1.7% | 26.6% | 0.1% | |
| 0.0% | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | |
| – | – | – | – | – | – | – | – | 3.5% | 0.4% | -0.1% | – | – | |
| 381.9% | – | – | – | – | – | – | – | 7.1% | 74.4% | 20.7% | -19.5% | 24.3% | |
| -117.3% | – | – | – | – | – | – | – | 7.6% | 5.9% | -9.6% | 2.1% | 0.7% | |
| -499.2% | – | – | – | – | – | – | – | -2,570.9% | 1,264.6% | -30.3% | 21.6% | -37.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.